Valneva shares jump 30% after saying vaccine candidate outperformed AstraZeneca's

Valneva /zigman2/quotes/202377434/delayed FR:VLA -1.53% shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's /zigman2/quotes/203048482/delayed UK:AZN +1.57% in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.

/zigman2/quotes/202377434/delayed

Add to watchlist FR:VLA

Valneva SE

FR : France: Euronext Paris

€ 6.18

-0.10 -1.53%

Volume: 455,642

Feb. 8, 2023 5:36p

P/E Ratio

N/A

Dividend Yield

N/A

Market Cap

€867.59 million

Rev. per Employee

N/A

/zigman2/quotes/203048482/delayed

Add to watchlist UK:AZN

AstraZeneca PLC

UK : U.K.: London

10,752.00 p

+166.00 +1.57%

Volume: 1.64M

Feb. 8, 2023 4:35p

P/E Ratio

98.03

Dividend Yield

2.06%

Market Cap

£164.06 billion

Rev. per Employee

£426,154